Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Jian Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5760-6690; OpenAlex author ID A5100603379. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers

Papers 6

  1. Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells. Co-author DOI 10.1186/s12906-024-04425-1↗
  2. Research Progress of Neural Invasion in Pancreatic Cancer. Last author DOI 10.2174/1568009623666230817105221↗
  3. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00261-021-03089-6↗
  4. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. First author DOI 10.1093/abbs/gmz071↗
  5. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer. Last author DOI 10.3892/ijo.2016.3772↗
  6. Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells. Last author DOI 10.1186/s12906-015-0640-5↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Luo · 3 shared papers, 2017–2024 · strength 0.49
  2. Mengying Zhu · 1 shared paper, 2024 · strength 0.31
  3. Ting Zhang · 1 shared paper, 2024 · strength 0.28
  4. Yifan Sun · 1 shared paper, 2024 · strength 0.28
  5. Xu Gong · 1 shared paper, 2021 · strength 0.22
  6. Lijun Qian · 1 shared paper, 2021 · strength 0.22
  7. Zhifang Gui · 2 shared papers, 2015–2017 · strength 0.15
  8. Songmei Lou · 1 shared paper, 2019 · strength 0.10
  9. Xing Liu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.